Rafferty Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41,255
| Closed | -$323K | – | 1152 |
|
|
2024
Q4 | $323K | Buy |
41,255
+6,178
| +18% | +$48.4K | ﹤0.01% | 1014 |
|
|
2024
Q3 | $461K | Buy |
+35,077
| New | +$461K | ﹤0.01% | 948 |
|
|
2022
Q4 | – | Sell |
-101,824
| Closed | -$1.47M | – | 1160 |
|
|
2022
Q3 | $1.47M | Buy |
101,824
+51,228
| +101% | +$739K | 0.02% | 580 |
|
|
2022
Q2 | $766K | Sell |
50,596
-89,711
| -64% | -$1.36M | 0.01% | 720 |
|
|
2022
Q1 | $1.67M | Buy |
140,307
+63,731
| +83% | +$757K | 0.01% | 665 |
|
|
2021
Q4 | $1.24M | Buy |
76,576
+35,991
| +89% | +$583K | 0.01% | 793 |
|
|
2021
Q3 | $1.16M | Sell |
40,585
-5,120
| -11% | -$146K | 0.01% | 773 |
|
|
2021
Q2 | $1.55M | Sell |
45,705
-31,677
| -41% | -$1.07M | 0.01% | 751 |
|
|
2021
Q1 | $2.34M | Buy |
77,382
+71,969
| +1,330% | +$2.18M | 0.02% | 581 |
|
|
2020
Q4 | $268K | Sell |
5,413
-14,619
| -73% | -$724K | ﹤0.01% | 864 |
|
|
2020
Q3 | $769K | Buy |
20,032
+12,972
| +184% | +$498K | 0.01% | 617 |
|
|
2020
Q2 | $305K | Buy |
+7,060
| New | +$305K | ﹤0.01% | 823 |
|
|
2020
Q1 | – | Sell |
-16,962
| Closed | -$530K | – | 818 |
|
|
2019
Q4 | $530K | Buy |
+16,962
| New | +$530K | 0.01% | 678 |
|